Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Cambridge, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Sarepta Therapeutics, Inc. has filed 1,527 SEC EDGAR filings since 28 Jan 1997

SEC filing history

Showing 1-25 of 52 matching filings.

Per page
25
Current page
1
10-Q File 001-14895

SRPT Q2 2021 10-Q

Filing date
04 Aug 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
10-Q File 001-14895

SRPT Q1 2021 10-Q

Filing date
05 May 2021
Reporting date
31 Mar 2021
Next action
Verify source filing
10-Q File 001-14895

Q3 2020 10-Q

Filing date
05 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
10-Q File 001-14895

Q2 2020 10-Q

Filing date
05 Aug 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
10-Q File 001-14895

Q1 2020 10-Q

Filing date
06 May 2020
Reporting date
31 Mar 2020
Next action
Verify source filing
10-Q File 001-14895

Q3 2019 10-Q

Filing date
07 Nov 2019
Reporting date
30 Sep 2019
Next action
Verify source filing
10-Q File 001-14895

Q2 2019 10-Q

Filing date
07 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
10-Q File 001-14895

SRPT Q1 2019 10-Q

Filing date
08 May 2019
Reporting date
31 Mar 2019
Next action
Verify source filing
10-Q/A File 001-14895

10-Q/A

Filing date
31 Oct 2018
Reporting date
30 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-14895

SRPT Q3 2018 10-Q FILING

Filing date
31 Oct 2018
Reporting date
30 Sep 2018
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .